Steinbächer M, Rieden K, Bihl H, Georgi P
Rofo. 1987 May;146(5):555-8. doi: 10.1055/s-2008-1048539.
Ninety-one radiologically confirmed osteolytic metastases in 30 patients with hypernephromas were studied with regard to their uptake of 99mTc-MDP and this was compared with the radiological findings. In 16% of the radiologically proven metastases, there was no correlation with their isotope uptake. Compared with other bone metastases whose isotope uptake has been studied and described in the literature, there appears to be a higher proportion of hypernephroma secondaries that do not show uptake of 99mTc-MDP.
对30例肾细胞癌患者的91处经放射学证实的溶骨性转移灶进行了99mTc-MDP摄取情况的研究，并与放射学检查结果进行了比较。在16%经放射学证实的转移灶中，其同位素摄取情况与转移灶不相关。与文献中已研究和描述过同位素摄取情况的其他骨转移相比，肾细胞癌继发的转移灶中不显示99mTc-MDP摄取的比例似乎更高。
